Skip to content

13F-HR filed by MONTANOVA CAPITAL, LLC

MONTANOVA CAPITAL, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 95 holding rows worth $5,164,999,000.

Accession
0001172661-22-000824
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 95 entries on the cover page, a total value of $5,164,999,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,164,999,000 with VALUE read as thousands by filing date, 13F file number 028-15929. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Amazon.com, Inc023135106COM108,030$360,209,000thousands by filing date
Microsoft Corp594918104COM865,000$290,917,000thousands by filing date
UnitedHealth Group Inc91324P102COM456,790$229,373,000thousands by filing date
Adobe Inc00724F101COM392,207$222,405,000thousands by filing date
OTIS WORLDWIDE CORP COM68902V107Stock2,484,580$216,332,000thousands by filing date
Union Pacific Corporation907818108COM808,020$203,564,000thousands by filing date
TAPESTRY INC COM876030107Stock4,547,460$184,627,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM270,470$180,468,000thousands by filing date
GFL ENVIRONMENTAL INC SUB VTG SHS36168Q104Stock4,627,040$175,133,000thousands by filing date
LAUDER ESTEE COS INC CL A518439104Stock449,360$166,353,000thousands by filing date
CENCORA INC COM03073E105Stock1,243,810$165,290,000thousands by filing date
IQVIA HLDGS INC COM46266C105Stock559,760$157,931,000thousands by filing date
Analog Devices,Inc.032654105COM819,310$144,010,000thousands by filing date
RH74967X103COM249,920$133,942,000thousands by filing date
QUANTA SVCS INC74762E102COM1,163,015$133,351,000thousands by filing date
MONSTER BEVERAGE CORP NEW COM61174X109Stock1,143,700$109,841,000thousands by filing date
CARVANA CO CL A146869102Stock427,807$99,161,000thousands by filing date
HILTON WORLDWIDE HLDGS INC COM43300A203Stock599,022$93,441,000thousands by filing date
OPENDOOR TECHNOLOGIES INC683712103COM6,168,996$90,129,000thousands by filing date
MasterCard, Inc57636Q104COM250,270$89,927,000thousands by filing date
CANO HEALTH INC13781Y103COM9,872,990$87,968,000thousands by filing date
ALIGHT INC01626W101COM CL A7,810,000$84,426,000thousands by filing date
MARRIOTT INTL INC NEW CL A571903202Stock493,640$81,569,000thousands by filing date
DECKERS OUTDOOR CORP243537107COM216,230$79,207,000thousands by filing date
ROYALTY PHARMA PLCG7709Q104SHS CLASS A1,967,273$78,396,000thousands by filing date
Danaher Corporation235851102COM220,200$72,448,000thousands by filing date
BLOCK INC CL A852234103Stock429,984$69,447,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK1,251,946$65,527,000thousands by filing date
TE CONNECTIVITY LTDH84989104SHS382,623$61,732,000thousands by filing date
NATERA INC COM632307104Stock636,160$59,411,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM402,789$59,085,000thousands by filing date
RIVIAN AUTOMOTIVE INC COM CL A76954A103Stock507,830$52,657,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock3,572,419$50,014,000thousands by filing date
COPART INC COM217204106Stock305,000$46,244,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK2,375,571$42,024,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM485,242$40,804,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM1,177,374$38,700,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM2,437,795$36,274,000thousands by filing date
WARBY PARKER INC93403J106CL A COM733,402$34,147,000thousands by filing date
KBR INC COM48242W106Stock685,500$32,644,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q200COM NEW2,638,775$31,349,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock2,519,700$30,841,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock1,081,532$29,461,000thousands by filing date
ETSY INC29786A106COM122,158$26,745,000thousands by filing date
MARQETA INC57142B104CLASS A COM1,467,368$25,195,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM1,409,956$23,574,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM1,746,300$23,104,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW245,800$22,845,000thousands by filing date
HERON THERAPEUTICS INC427746102COM2,486,340$22,700,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock692,000$21,618,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM1,247,468$20,346,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM1,218,792$19,452,000thousands by filing date
CHIMERIX INC COM16934W106Stock2,766,619$17,789,000thousands by filing date
Inflarx NvN44821101COM3,285,000$15,637,000thousands by filing date
POINT BIOPHARMA GLOBAL INC730541109COM2,672,863$14,968,000thousands by filing date
MEREO BIOPHARMA GROUP PLC589492107CMN9,142,067$14,627,000thousands by filing date
GRABHLDGSLTDFCLASSCLASSAG4124C109STOK2,000,000$14,260,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM2,571,000$12,212,000thousands by filing date
PHARVARIS NVN69605108COMMON STOCK827,540$11,908,000thousands by filing date
SOLID BIOSCIENCES INC COM NEW83422E105Stock6,287,193$11,003,000thousands by filing date
BOLT BIOTHERAPEUTICS INC097702104COM2,230,250$10,928,000thousands by filing date
DICE THERAPEUTICS INC23345J104COM410,000$10,377,000thousands by filing date
AMBRX BIOPHARMA, INC. SPONSORED ADR02290A102COM1,057,735$9,551,000thousands by filing date
TERNS PHARMACEUTICALS INC COM880881107Stock1,238,800$8,758,000thousands by filing date
MOLECULAR PARTNERS AG60853G106ADS400,000$7,672,000thousands by filing date
SIO GENE THERAPIES INC829399104COM5,914,000$7,629,000thousands by filing date
INOZYME PHARMA INC45790W108COM1,013,216$6,910,000thousands by filing date
GEMINI THERAPEUTICS INC36870G105CMN2,372,267$6,903,000thousands by filing date
ROIVANT SCIENCES LTDG76279101SHS681,528$6,870,000thousands by filing date
ORIC PHARMACEUTICALS INC68622P109COM440,696$6,478,000thousands by filing date
Milestone Pharmaceuticals Inc59935V107COM851,291$5,576,000thousands by filing date
OTONOMY INC68906L105COM2,678,115$5,570,000thousands by filing date
ABCELLERA BIOLOGICS INC COM00288U106Stock367,100$5,250,000thousands by filing datecall
RESEARCH ALLIANCE CORP II760873109CMN500,000$4,885,000thousands by filing date
ALLOGENE THERAPEUTICS INC019770106COM265,116$3,956,000thousands by filing date
NUVALENT INC COM670703107Stock200,000$3,808,000thousands by filing date
IMMUNEERING CORP45254E107CLASS A COM200,000$3,234,000thousands by filing date
OMEGA ALPHA SPACG6749V107CL A300,000$2,931,000thousands by filing date
EUROPEAN BIOTECH ACQUTN CORPG3167F102CLASS A ORD SHS300,000$2,907,000thousands by filing date
Benitec Biopharma, Inc.08205P100common769,000$2,015,000thousands by filing date
OPY ACQUISITION CORP I671005205UNIT 09/22/2026200,000$2,000,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T108CMN200,000$1,964,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN200,000$1,960,000thousands by filing date
ENTRADA THERAPEUTICS INC COM29384C108Stock106,000$1,815,000thousands by filing date
CANO HEALTH INC13781Y111WARR674,566$1,612,000thousands by filing date
DECIBEL THERAPEUTICS INC24343R106COM263,600$1,226,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W106CMN99,999$976,000thousands by filing date
FRAZIER LIFESCIENCES ACQU COG3710A105CMN87,498$853,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK34,600$821,000thousands by filing date
SORRENTO THERAPEUTICS INC83587F202COMMON STOCK105,744$492,000thousands by filing date
FINSERV ACQUISITION CORP II31809Y111*W EXP 02/17/202273,149$169,000thousands by filing date
EUROPEAN BIOTECH ACQUTN CORPG3167F128*W EXP 03/06/202100,000$60,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T124WTS66,666$45,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W122*W EXP 10/23/20233,333$19,000thousands by filing date
FRAZIER LIFESCIENCES ACQU COG3710A113WTS29,166$17,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-22-000824this filing2022-02-14acceptance time not in the bulk data set